Biblio
“Non-genomic actions of progesterone and estrogens in regulating reproductive events in domestic animals.”, Vet J, vol. 176, no. 3, pp. 270-80, 2008.
, “Intravenous neutralization of vascular endothelial growth factor reduces vascular function/permeability of the ovary and prevents development of OHSS-like symptoms in rhesus monkeys”, Journal of Ovarian Research, vol. 103338326171387143209031451066514212414149333279571181961236205949314173139239289627768213716881676712312133141, no. 1, 2017.
, “Effects of steroid ablation and progestin replacement on the transcriptome of the primate corpus luteum during simulated early pregnancy”, MHR: Basic science of reproductive medicine, vol. 201112157117181391492215071326313657795714125821511418093445315011608849150637552691441770108695, no. 3, pp. 222 - 234, 2013.
, “Analysis of microarray data from the macaque corpus luteum; the search for common themes in primate luteal regression”, Molecular Human Reproduction, vol. 17361582139149221501944911020465684117121802562804951501283161237342111771019958, no. 32311153216353142512611365822512396181 Suppl Proceedings, pp. 143 - 151, 2011.
, “Chronic hyperandrogenemia and western-style diet beginning at puberty reduces fertility and increases metabolic dysfunction during pregnancy in young adult, female macaques”, Human Reproduction, vol. 3393429677108333836185112611196622791322410404811211651291131867329834115, no. 4Suppl. 2, pp. 694 - 705, 2018.
, “Progesterone suppresses an oxytocin-stimulated signal pathway in COS-7 cells transfected with the oxytocin receptor”, Steroids, vol. 73, no. 14, pp. 1367 - 1374, 2008.
, “Changes in immune cell distribution and their cytokine/chemokine production during regression of the rhesus macaque corpus luteum†”, Biology of Reproduction, vol. 961343141151149912961011611393174622123922150151726141448510912688251117791344141912474708968185425217685113220, no. 6, pp. 1210 - 1220, 2017.
, “Quantification of dynamic changes to blood volume and vascular flow in the primate corpus luteum during the menstrual cycle”, Journal of Medical Primatology, vol. 433395839043712243841429931713714138154128908474, no. 6Suppl 8, pp. 445 - 454, 2014.
, “Non-genomic actions of progesterone and estrogens in regulating reproductive events in domestic animals”, The Veterinary Journal, vol. 176, no. 3, pp. 270 - 280, 2008.
, “Knockdown of Progesterone Receptor (PGR) in Macaque Granulosa Cells Disrupts Ovulation and Progesterone Production1”, Biology of Reproduction, vol. 94151414097933484432385953983354791541726412218172015181115355102829123509425573193465597616515268, no. 5, 2016.
, “Progesterone inhibition of oxytocin signaling in endometrium”, Frontiers in Neuroscience, vol. 7, 2013.
, “Evaluation of antral follicle growth in the macaque ovary during the menstrual cycle and controlled ovarian stimulation by high-resolution ultrasonography”, American Journal of Primatology, vol. 7127698025286881002132211351227250712107, no. 5, pp. 384 - 392, 2009.
, “Chronic hyperandrogenemia in the presence and absence of a western-style diet impairs ovarian and uterine structure/function in young adult rhesus monkeys”, Human Reproduction, vol. 332710437110567186037148358368815211239326492273063712837122257983799228836328913632323686313318, no. 1, pp. 128 - 139, 2017.
, “Nongenomic Action of Progesterone Inhibits Oxytocin-Induced Phosphoinositide Hydrolysis and Prostaglandin F 2α Secretion in the Ovine Endometrium”, Endocrinology, vol. 147, no. 2, pp. 937 - 942, 2006.
, “Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligands.”, J Med Chem, vol. 52, no. 18, pp. 5635-41, 2009.
, “Tumor-Promoting/Associated Inflammation and the Microenvironment: A State of the Science and New Horizons”, Hoboken, NJ, USA: John Wiley & Sons, Inc., 2018, pp. 473 - 510.
, “Drug repurposing in chemical genomics: can we learn from the past to improve the future?”, Current topics in medicinal chemistry, vol. 12, pp. 1883–1888, 2012.
, “Modeling of the Aryl Hydrocarbon Receptor (AhR) Ligand Binding Domain and Its Utility in Virtual Ligand Screening to Predict New AhR Ligands”, Journal of Medicinal Chemistry, vol. 52, no. 18, pp. 5635 - 5641, 2009.
, “Molecular basis of agonicity and antagonicity in the androgen receptor studied by molecular dynamics simulations”, Journal of Molecular Graphics and Modelling, vol. 27, no. 4, pp. 452 - 458, 2008.
, “Environmental immune disruptors, inflammation and carcinogenesis: A state of the science and new horizons”, Toxicology Letters, vol. 280, pp. S9 - S10, 2017.
, “Editorial: computational chemogenomics in drug design and discovery.”, Current topics in medicinal chemistry, vol. 12, p. 1867, 2012.
, “Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs”, Proceedings of the National Academy of Sciences, vol. 104, pp. 11927–11932, 2007.
“Binding Properties of the C-terminal Domain of VIAF”, Chemical biology & drug design, vol. 72, pp. 331–336, 2008.
, “Ligand selectivity for the acetylcholine binding site of the rat $\alpha$4$\beta$2 and $\alpha$3$\beta$4 nicotinic subtypes investigated by molecular docking”, Journal of medicinal chemistry, vol. 48, pp. 5123–5130, 2005.
, “Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligands”, Journal of medicinal chemistry, vol. 52, pp. 5635–5641, 2009.
,